Myocet liposomal

Medicinal product

(Invented) name

Myocet liposomal

Active substance (s)

Doksorubicino hidrochloridas

Strength

50 mg

Pharmaceutical form

milteliai, dispersija ir tirpiklis infuzinės dispersijos koncentratui

Route (s) of administration

leisti į veną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

ATC code (s)

L01DB01, Doxorubicin

Marketing authorisation holder

Cheplapharm Arzneimittel GmbH, Vokietija

Date of authorisation

2006-03-29

Date of renewal

Documents

Stage

Registruotas

Controlled?

Controlled substance type

Legal basis

8(3)

Procedure number

Marketing authorisation procedure

Centrinė registracija

Qualitative and quantitative composition

Dispersion and solvent for concentrate for dispersion for infusion	1 vnt.
Doksorubicino hidrochloridas	50 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
27365	29920	1029920	flakonas	N2 (rinkinys: milteliai+liposomos+buferinis tirpalas)		Receptinis	EU/1/00/141/001	Netiekiama	-	-	No	-	-
51536	65432	1065432	flakonas	N1 (rinkinys: milteliai+liposomos+buferinis tirpalas)		Receptinis	EU/1/00/141/002	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2006-03-29	Registruotas